Celldex Therapeutics, Inc.-Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
- ADAB97B7-2425-4BDC-991D-462AC28E757A
- Pages: 84
- July 2018
- Region : North America
- MarketLine
- Equity Research Report
- Details
- Table Of Content
- Licence Rights
- Section Purchase
Details
Celldex Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary
Marketline's Celldex Therapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Celldex Therapeutics, Inc. since January2007.
Synopsis
Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.
Key Highlights
This report includes Celldex Therapeutics, Inc.'s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.
The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Celldex Therapeutics, Inc.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.
Scope
- Provides intelligence on Celldex Therapeutics, Inc.'s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Celldex Therapeutics, Inc. and its subsidiaries since 2007.
- Information about key financial and legal advisors for Celldex Therapeutics, Inc.'s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.
Reasons to buy
- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Celldex Therapeutics, Inc.'s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors' business structure and growth strategies.
Table Of Content
Scope
Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions - Overview 8
Mergers and Acquisitions - Deal reports 9
PARTNERSHIP 20
Partnership - Deal reports 20
CAPITAL RAISING 54
Capital Raising - Overview 54
Capital Raising - Deal reports 55
Divestments - Deal reports 72
APPENDIX 74
Contact Us 74
About MarketLine Financial Deals Database 74
Deal Definition and Methodology 76
About MarketLine 83
List Of Figure
List of Figures
Figure 1: Celldex Therapeutics M&A volume and value trend (2014-YTD2018)
Figure 2: Celldex Therapeutics M&A activity by geography (2014-YTD2018)
Figure 3: Celldex Therapeutics capital raising volume and value trend (2014-YTD2018)
Figure 4: Celldex Therapeutics capital raising by deal type (2014-YTD2018)
List Of Table
List of Tables
Table 1: Celldex Therapeutics M&A volume and value trend (2014-YTD2018)
Table 2: Celldex Therapeutics M&A activity by geography (2014-YTD2018)
Table 3: Celldex Therapeutics capital raising volume and value trend (2014-YTD2018)
Table 4: Celldex Therapeutics capital raising by deal type (2014-YTD2018)
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
Celldex Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary
Marketline's Celldex Therapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Celldex Therapeutics, Inc. since January2007.
Synopsis
Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.
Key Highlights
This report includes Celldex Therapeutics, Inc.'s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.
The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Celldex Therapeutics, Inc.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.
Scope
- Provides intelligence on Celldex Therapeutics, Inc.'s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Celldex Therapeutics, Inc. and its subsidiaries since 2007.
- Information about key financial and legal advisors for Celldex Therapeutics, Inc.'s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.
Reasons to buy
- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Celldex Therapeutics, Inc.'s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors' business structure and growth strategies.
Scope
Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions - Overview 8
Mergers and Acquisitions - Deal reports 9
PARTNERSHIP 20
Partnership - Deal reports 20
CAPITAL RAISING 54
Capital Raising - Overview 54
Capital Raising - Deal reports 55
Divestments - Deal reports 72
APPENDIX 74
Contact Us 74
About MarketLine Financial Deals Database 74
Deal Definition and Methodology 76
About MarketLine 83
List Of Figure
List of Figures
Figure 1: Celldex Therapeutics M&A volume and value trend (2014-YTD2018)
Figure 2: Celldex Therapeutics M&A activity by geography (2014-YTD2018)
Figure 3: Celldex Therapeutics capital raising volume and value trend (2014-YTD2018)
Figure 4: Celldex Therapeutics capital raising by deal type (2014-YTD2018)
List Of Table
List of Tables
Table 1: Celldex Therapeutics M&A volume and value trend (2014-YTD2018)
Table 2: Celldex Therapeutics M&A activity by geography (2014-YTD2018)
Table 3: Celldex Therapeutics capital raising volume and value trend (2014-YTD2018)
Table 4: Celldex Therapeutics capital raising by deal type (2014-YTD2018)
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Related Reports
Page 234 | 
September 2019
Page 140 | July 2019
Page 181 | July 2019
Page 130 | May 2019
Page 155 | April 2019